- Home
- Publications
- Publication Search
- Publication Details
Title
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1139
Publisher
MDPI AG
Online
2020-05-05
DOI
10.3390/cancers12051139
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BRCA1/P53: Two strengths in cancer chemoprevention
- (2020) Liliana Raimundo et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- p53, cancer and the immune response
- (2020) Julianna Blagih et al. JOURNAL OF CELL SCIENCE
- Mesenchymal stem cells used as carrier cells of oncolytic adenovirus results in enhanced oncolytic virotherapy
- (2020) Khaphetsi Joseph Mahasa et al. Scientific Reports
- Human chimeric antigen receptor macrophages for cancer immunotherapy
- (2020) Michael Klichinsky et al. NATURE BIOTECHNOLOGY
- Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma
- (2019) A-Rum Yoon et al. CANCER RESEARCH
- Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
- (2019) Julia Niemann et al. Nature Communications
- A tumor targeting oncolytic adenovirus can improve therapeutic outcomes in chemotherapy resistant metastatic human breast carcinoma
- (2019) Ali Sakhawat et al. Scientific Reports
- State‐of‐the‐art human adenovirus vectorology for therapeutic approaches
- (2019) Jian Gao et al. FEBS LETTERS
- Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
- (2018) Vincenzo Cerullo et al. CURRENT CANCER DRUG TARGETS
- The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic
- (2018) Wei-Wei Zhang et al. HUMAN GENE THERAPY
- Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
- (2018) Frederick F. Lang et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
- (2018) M. Garofalo et al. JOURNAL OF CONTROLLED RELEASE
- Rapid Cloning of Novel Rhesus Adenoviral Vaccine Vectors
- (2018) Peter Abbink et al. JOURNAL OF VIROLOGY
- Seamless assembly of recombinant adenoviral genomes from high-copy plasmids
- (2018) Jessica J. Miciak et al. PLoS One
- Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination
- (2018) Wenli Zhang et al. Human Gene Therapy Methods
- Designer Oncolytic Adenovirus: Coming of Age
- (2018) Alexander Baker et al. Cancers
- First-in-child trial of celyvir (autologous mesenchymal stem cells carrying the oncolytic virus ICOVIR-5) in patients with relapsed and refractory pediatric solid tumors.
- (2018) Manuel Ramirez et al. JOURNAL OF CLINICAL ONCOLOGY
- CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy
- (2018) Sadia Zafar et al. OncoImmunology
- Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies
- (2018) Mariangela Garofalo et al. Viruses-Basel
- Viral vector-based delivery of CRISPR/Cas9 and donor DNA for homology directed repair in an in vitro model for canine hemophilia B
- (2018) Jian Gao et al. Molecular Therapy-Nucleic Acids
- De-novo and acquired resistance to immune checkpoint targeting
- (2017) Nicholas L Syn et al. LANCET ONCOLOGY
- An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results
- (2017) Vignesh T. Packiam et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An Engineered Virus Library as a Resource for the Spectrum-wide Exploration of Virus and Vector Diversity
- (2017) Wenli Zhang et al. Cell Reports
- Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
- (2017) Ali Sakhawat et al. Journal of Cancer
- Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection
- (2017) Rocio Garcia-Carbonero et al. Journal for ImmunoTherapy of Cancer
- Combining Oncolytic Adenovirus with Radiation—A Paradigm for the Future of Radiosensitization
- (2017) Sean M. O’Cathail et al. Frontiers in Oncology
- The Efficacy of Oncolytic Adenovirus Is Mediated by T-cell Responses against Virus and Tumor in Syrian Hamster Model
- (2016) Xiaozhu Li et al. CLINICAL CANCER RESEARCH
- Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFN Combined with Chemotherapy
- (2016) D. H. Sterman et al. CLINICAL CANCER RESEARCH
- Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironment
- (2016) E Eriksson et al. GENE THERAPY
- Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer
- (2016) I. Liikanen et al. MOLECULAR CANCER THERAPEUTICS
- Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer
- (2016) Di Yu et al. NEUROENDOCRINOLOGY
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
- (2016) Weiping Zou et al. Science Translational Medicine
- Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
- (2016) Tuuli Ranki et al. Journal for ImmunoTherapy of Cancer
- Two distinct effector memory cell populations of WT1 (Wilms’ tumor gene 1)-specific cytotoxic T lymphocytes in acute myeloid leukemia patients
- (2015) Yoshiki Nakae et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Clinical and Biological Effects of an Agonist Anti-CD40 Antibody: A Cancer Research UK Phase I Study
- (2015) P. Johnson et al. CLINICAL CANCER RESEARCH
- Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA
- (2015) YANG GAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21
- (2015) XIAOMEI LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Human mastadenovirus type 70: a novel, multiple recombinant species D mastadenovirus isolated from diarrhoeal faeces of a haematopoietic stem cell transplantation recipient
- (2015) Elias Hage et al. JOURNAL OF GENERAL VIROLOGY
- CD8+CD103+Tumor–Infiltrating Lymphocytes Are Tumor-Specific Tissue-Resident Memory T Cells and a Prognostic Factor for Survival in Lung Cancer Patients
- (2015) Fayçal Djenidi et al. JOURNAL OF IMMUNOLOGY
- Human Adenovirus 52 Uses Sialic Acid-containing Glycoproteins and the Coxsackie and Adenovirus Receptor for Binding to Target Cells
- (2015) Annasara Lenman et al. PLoS Pathogens
- The Human Agonistic CD40 Antibody ADC-1013 Eradicates Bladder Tumors and Generates T-cell-Dependent Tumor Immunity
- (2014) S. M. Mangsbo et al. CLINICAL CANCER RESEARCH
- Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
- (2014) Mikko Siurala et al. INTERNATIONAL JOURNAL OF CANCER
- Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
- (2014) Svend O. Freytag et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites
- (2013) V.A. Jennings et al. INTERNATIONAL JOURNAL OF CANCER
- A Preclinical Evaluation of Neural Stem Cell–Based Cell Carrier for Targeted Antiglioma Oncolytic Virotherapy
- (2013) Atique U. Ahmed et al. JNCI-Journal of the National Cancer Institute
- Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement
- (2013) Zhili Xu et al. NATURE MEDICINE
- Molecular evolution of human adenoviruses
- (2013) Christopher M. Robinson et al. Scientific Reports
- The Timing of Neural Stem Cell-Based Virotherapy Is Critical for Optimal Therapeutic Efficacy When Applied With Radiation and Chemotherapy for the Treatment of Glioblastoma
- (2013) Alex L. Tobias et al. Stem Cells Translational Medicine
- Myeloid-derived suppressor cells as a Trojan horse
- (2013) Ping-Ying Pan et al. OncoImmunology
- Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) K. Oberg et al. ANNALS OF ONCOLOGY
- Macrophage Delivery of an Oncolytic Virus Abolishes Tumor Regrowth and Metastasis after Chemotherapy or Irradiation
- (2012) M. Muthana et al. CANCER RESEARCH
- Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells
- (2012) Robert A. Adair et al. INTERNATIONAL JOURNAL OF CANCER
- Human Telomerase Reverse Transcriptase (hTERT) Is a Novel Target of the Wnt/β-Catenin Pathway in Human Cancer
- (2012) Yong Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenovirus Serotype 26 Utilizes CD46 as a Primary Cellular Receptor and Only Transiently Activates T Lymphocytes following Vaccination of Rhesus Monkeys
- (2012) H. Li et al. JOURNAL OF VIROLOGY
- Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
- (2012) Otto Hemminki et al. MOLECULAR THERAPY
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting
- (2012) Jun Fu et al. NATURE BIOTECHNOLOGY
- Adenovirus receptors: implications for targeting of viral vectors
- (2012) Niklas Arnberg TRENDS IN PHARMACOLOGICAL SCIENCES
- Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors
- (2011) Jens Rüter et al. CANCER BIOLOGY & THERAPY
- Mining the adenovirus virome for oncolytics against multiple solid tumor types
- (2011) C Y Chen et al. CANCER GENE THERAPY
- Species D Adenoviruses as Oncolytics against B-cell Cancers
- (2011) C. Y. Chen et al. CLINICAL CANCER RESEARCH
- Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
- (2011) D. Yu et al. JOURNAL OF VIROLOGY
- A Comparative Study of Neural and Mesenchymal Stem Cell-Based Carriers for Oncolytic Adenovirus in a Model of Malignant Glioma
- (2011) Atique U. Ahmed et al. MOLECULAR PHARMACEUTICS
- Neural Stem Cell-based Cell Carriers Enhance Therapeutic Efficacy of an Oncolytic Adenovirus in an Orthotopic Mouse Model of Human Glioblastoma
- (2011) Atique U Ahmed et al. MOLECULAR THERAPY
- CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
- (2011) G. L. Beatty et al. SCIENCE
- A Novel Oncolytic Adenovirus Expressing Escherichia coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors
- (2010) Jufeng Zhang et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Oncolytic adenovirus based on serotype 3
- (2010) O Hemminki et al. CANCER GENE THERAPY
- Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
- (2010) Vincenzo Cerullo et al. CANCER RESEARCH
- Serotype-Specific Inactivation of the Cellular DNA Damage Response during Adenovirus Infection
- (2010) N. A. Forrester et al. JOURNAL OF VIROLOGY
- Minimal RB-responsive E1A Promoter Modification to Attain Potency, Selectivity, and Transgene-arming Capacity in Oncolytic Adenoviruses
- (2010) Juan J Rojas et al. MOLECULAR THERAPY
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14
- (2010) Hongjie Wang et al. NATURE MEDICINE
- The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis
- (2010) Emma C Nilsson et al. NATURE MEDICINE
- Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
- (2010) Justyna Leja et al. PLoS One
- Looking Inside Adenovirus
- (2010) S. C. Harrison SCIENCE
- Immune Checkpoint Proteins: A New Therapeutic Paradigm for Cancer—Preclinical Background: CTLA-4 and PD-1 Blockade
- (2010) Jeffrey Weber SEMINARS IN ONCOLOGY
- Targeting p53 for enhanced radio- and chemo-sensitivity
- (2009) Chao Lu et al. APOPTOSIS
- Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
- (2009) R. C. Carlisle et al. BLOOD
- Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
- (2009) I V Ulasov et al. BRITISH JOURNAL OF CANCER
- Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity
- (2009) E J Ilett et al. GENE THERAPY
- Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma
- (2009) Ranjana Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- Temporal Regulation of the Mre11-Rad50-Nbs1 Complex during Adenovirus Infection
- (2009) K. A. Karen et al. JOURNAL OF VIROLOGY
- Enzymatic assembly of DNA molecules up to several hundred kilobases
- (2009) Daniel G Gibson et al. NATURE METHODS
- The Janus faces of CD40 in cancer
- (2009) Angelica S.I. Loskog et al. SEMINARS IN IMMUNOLOGY
- Low-Dose Radiation Enhances Survivin-Mediated Virotherapy against Malignant Glioma Stem Cells
- (2008) S. Nandi et al. CANCER RESEARCH
- Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial
- (2008) S. Arai et al. CYTOTHERAPY
- Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery
- (2008) S H Thorne et al. GENE THERAPY
- The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
- (2008) David H. Lynch IMMUNOLOGICAL REVIEWS
- Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
- (2008) Irene Kuhn et al. PLoS One
- Evaluation of Twenty-One Human Adenovirus Types and One Infectivity-Enhanced Adenovirus for the Treatment of Malignant Melanoma
- (2007) Dennis Hoffmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started